| Market Size in 2025 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 32.99 Billion | USD 52.57 Billion | 5.31% | 2025 |
FrequentlyAsked Questions
Pneumothorax treatment is the use of different medical procedures and instruments to relieve pressure on the lungs.
The global pneumothorax treatment market is expected to benefit from the rising cases of punctured lungs worldwide.
According to study, the global pneumothorax treatment market size was worth around USD 32.99 billion in 2025 and is predicted to grow to around USD 52.57 billion by 2034.
The CAGR value of the pneumothorax treatment market is expected to be around 5.31% during 2026-2034.
The global pneumothorax treatment industry is projected to be restricted due to growing consumer preference for conservative treatments.
Rising popularity of ambulatory pneumothorax management and Artificial Intelligence (AI) integrations are the emerging trends and innovations impacting the pneumothorax treatment market.
The global pneumothorax treatment market has performed well so far and will offer similar trends in the coming years.
North America will contribute notably towards the pneumothorax treatment market value.
The global pneumothorax treatment market is led by players like Becton Dickinson and Company (BD), Medtronic, ATMOS MedizinTechnik, Cook Medical, Sinapi Biomedical, Teleflex Incorporated, Vygon, Merit Medical Systems, Cardinal Health, Utah Medical Products, Nobelpharma, Medela, Argon Medical Devices, Rocket Medical, and Getinge.
The report explores crucial aspects of the pneumothorax treatment market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients